WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Comments close on FDA's generative AI device framework Solventum clears its Restrata matrix for use under V.A.C. negative pressure therapy Medtronic takes a CE mark for five conduction system pacing pacemakers Paradromics hands Siemens Healthineers the imaging workup for its brain implant Empyrean submits a 510(k) for Vektra, its robotic brachytherapy system Masimo clears AFib detection on the Radius VSM wearable monitor Sequel clears the twiist insulin pump for adults with type 2 diabetes FTC issues a second request on the MiMedx purchase of Sanara MedTech Labcorp pays $722M upfront for BioReference testing assets Comments close on FDA's generative AI device framework Solventum clears its Restrata matrix for use under V.A.C. negative pressure therapy Medtronic takes a CE mark for five conduction system pacing pacemakers Paradromics hands Siemens Healthineers the imaging workup for its brain implant Empyrean submits a 510(k) for Vektra, its robotic brachytherapy system Masimo clears AFib detection on the Radius VSM wearable monitor Sequel clears the twiist insulin pump for adults with type 2 diabetes FTC issues a second request on the MiMedx purchase of Sanara MedTech Labcorp pays $722M upfront for BioReference testing assets

Milestone

Oura takes ISO 13485 for software ten days after shelving its $2.2B IPO

MedDevice Startups Staff · Oct 9 · 2 min read · Via Medical Design & Outsourcing

Oura said on October 9 that its software quality management system is certified to ISO 13485. The scope covers design, development, manufacturing and distribution of medical device software for digital health applications that monitor and analyze vital and non-vital physiological parameters. Oura points to Fertile Window, CE marked and regulated as a Class I device in the EU, as an example inside that scope. The company says the certificate gives it a basis to build medical device software and to evaluate regulatory pathways in the US and other markets.

The announcement lands ten days after Oura postponed a $2.2B Nasdaq IPO, which it blamed on uncertainty in the IPO market. A quality system certificate is an audit outcome, not a clearance. What it buys is that the design history files behind any future US submission get built under one system from the start, rather than reconstructed when the submission is due.

Questions & Answers

What did Oura announce about ISO 13485?

On October 9, 2026, Oura said it certified its software quality management system to ISO 13485. The scope covers design, development, manufacturing and distribution of medical device software for digital health applications built on its wearables.

Does Oura's ISO 13485 certification mean it has FDA clearance?

No. ISO 13485 certification is a quality management system audit, not a regulatory clearance. Oura says the certification gives it a basis to develop medical device software and to evaluate regulatory pathways in the United States and other markets.

What happened to Oura's IPO?

Oura postponed a planned $2.2 billion Nasdaq IPO, citing uncertainty in the IPO market. Its ISO 13485 announcement followed about ten days later, on October 9, 2026.

← Back to Startups